Relationship between pollen concentrations and shor-acting B2-agonists (SABA) bronchodilator sales in central France: a daily time-series analysis over a 5-year period. Source: International Congress 2018 – Asthma: clinical screening tools Year: 2018
Predictors of excessive short-acting beta2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database. Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020
Effect of combined inhaled corticosteroid-formoterol therapy on short-acting beta2-agonist use in Poland: a retrospective analysis of pharmacy reports Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma Year: 2020
Prevalence of the use of oral corticosteroids in asthma – a 3-year analysis in Germany Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019
Trends of short-acting beta-agonist (SABA) surrounding days of high use in asthma and COPD Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019
Seasonal variation in COPD exacerbation rates: budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) at two ICS dose levels in the ETHOS trial Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD Year: 2020
Safety of formoterol turbuhaler used as reliever in asthma: relationship with age and baseline treatment including regular long-acting β2 -agonists (the RELIEF study) Source: Eur Respir J 2002; 20: Suppl. 38, 44s Year: 2002
Relationship between baseline rescue medication use and reductions in COPD exacerbation rates: a subgroup analysis of the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021
Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening Source: Eur Respir J 2001; 17: 1083-1088 Year: 2001
Outdoor mold spore levels and drug consumption for drug treated seasonal allergic rhino-conjunctivitis (TSAR): a 6-year study in France Source: International Congress 2017 – Smoking, apnoea, infection, allergens and other factors Year: 2017
Total costs according to reliever use of formoterol turbuhaler in asthma: results from the RELIEF worldwide randomized effectiveness study, stratified by maintenance medication levels Source: Eur Respir J 2002; 20: Suppl. 38, 43s Year: 2002
Three-year prospective cohort study of growth in asthmatic children prescribed appropriate inhaled corticosteroid (ICS) doses Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004
Comparative analysis of asthma and COPD incidence in Serbia - a 10-year period Source: Eur Respir J 2002; 20: Suppl. 38, 315s Year: 2002
COPD exacerbation rates by month in the ETHOS trial with budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) at two ICS dose levels Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020
Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with fixed dosing – a 5-month study in Canada Source: Eur Respir J 2003; 22: Suppl. 45, 411s Year: 2003
Gender differences in the prevalence of severe asthma. Data from an island population database of high dose inhaled corticosteroid prescription Source: Eur Respir J 2004; 24: Suppl. 48, 140s Year: 2004
The effect of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A real practice analysis in Italy Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014
Asthma control in general practice with inhaled corticosteroids and long-acting B2-agonists administered as a fixed or free combination at stable dosage: the ALISE survey Source: Eur Respir J 2002; 20: Suppl. 38, 397s Year: 2002
Efficacy of the novel very long-acting β2-agonist carmoterol following 7 days once daily dosing: comparison with twice daily formoterol in patient with persistent asthma Source: Eur Respir J 2006; 28: Suppl. 50, 665s Year: 2006
Adding montelukast versus doubling the budesonide dose in persistent asthma: a subgroup analysis of the COMPACT study Source: Eur Respir J 2002; 20: Suppl. 38, 388s Year: 2002